Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

More daily smokers with tuberculosis receiving a mobile health intervention achieved self-reported and biochemically verified ...

The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of ...

UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

In a federally funded clinical trial led by Johns Hopkins Medicine, people with tuberculosis infections (but not HIV) in two ...

Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and ...

New research is now casting doubt on the true number of tuberculosis cases. That could carry significant implications for patient care and well-being.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.